Cellectar Biosciences Inc - ESG Rating & Company Profile powered by AI
The Sustainability score for Cellectar Biosciences Inc indicates its reporting of the United Nations SDGs. The assessment of Cellectar Biosciences Inc was prepared by All Street Sevva using proprietary AI. Browse to the end of this webpage for potential risks for Cellectar Biosciences Inc based on sector, location and size.
Cellectar Biosciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.6; made up of an environmental score of 5.3, social score of 1.6 and governance score of 4.0.
3.6
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1132 | Taro Pharmaceutical Industries Ltd | 3.7 | Medium |
1132 | Traphaco JSC | 3.7 | Medium |
1144 | Cellectar Biosciences Inc | 3.6 | Medium |
1144 | CellSeed Inc | 3.6 | Medium |
1144 | AroCell AB (publ) | 3.6 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Cellectar Biosciences Inc have an accelerator or VC vehicle to help deliver innovation?
Does Cellectar Biosciences Inc disclose current and historical energy intensity?
Does Cellectar Biosciences Inc report the average age of the workforce?
Does Cellectar Biosciences Inc reference operational or capital allocation in relation to climate change?
Does Cellectar Biosciences Inc disclose its ethnicity pay gap?
Does Cellectar Biosciences Inc disclose cybersecurity risks?
Does Cellectar Biosciences Inc offer flexible work?
Does Cellectar Biosciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Cellectar Biosciences Inc disclose the number of employees in R&D functions?
Does Cellectar Biosciences Inc conduct supply chain audits?
Does Cellectar Biosciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Cellectar Biosciences Inc conduct 360 degree staff reviews?
Does Cellectar Biosciences Inc disclose the individual responsible for D&I?
Does Cellectar Biosciences Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Cellectar Biosciences Inc disclose current and / or historical scope 2 emissions?
Does Cellectar Biosciences Inc disclose water use targets?
Does Cellectar Biosciences Inc have careers partnerships with academic institutions?
Did Cellectar Biosciences Inc have a product recall in the last two years?
Does Cellectar Biosciences Inc disclose incidents of discrimination?
Does Cellectar Biosciences Inc allow for Work Councils/Collective Agreements to be formed?
Has Cellectar Biosciences Inc issued a profit warning in the past 24 months?
Does Cellectar Biosciences Inc disclose parental leave metrics?
Does Cellectar Biosciences Inc disclose climate scenario or pathway analysis?
Does Cellectar Biosciences Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Cellectar Biosciences Inc disclose the pay ratio of women to men?
Does Cellectar Biosciences Inc support suppliers with sustainability related research and development?
Does Cellectar Biosciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Cellectar Biosciences Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Cellectar Biosciences Inc involved in embryonic stem cell research?
Does Cellectar Biosciences Inc disclose GHG and Air Emissions intensity?
Does Cellectar Biosciences Inc disclose its waste policy?
Does Cellectar Biosciences Inc report according to TCFD requirements?
Does Cellectar Biosciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Cellectar Biosciences Inc disclose energy use targets?
Does Cellectar Biosciences Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Cellectar Biosciences Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Cellectar Biosciences Inc
These potential risks are based on the size, segment and geographies of the company.
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients; and Phase I study for various pediatric cancers, r/r head and neck cancers, and R/R MM. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative PDC programs with Avicenna Oncology GMBH to develop CLR 2000 Series; Orano Med to develop CLR 12120 Series; IntoCell Inc; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.